Applied DNA Sciences (NASDAQ: APDN)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | -0.230 | 0.1000 | ||||
REV | 4.500M | 6.147M | 1.647M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Applied DNA Sciences (NASDAQ: APDN) through any online brokerage.
Other companies in Applied DNA Sciences’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codex DNA (NASDAQ:DNAY), Personalis (NASDAQ:PSNL), IsoPlexis (NASDAQ:ISO) and Quoin Pharmaceuticals (NASDAQ:QNRX).
The latest price target for Applied DNA Sciences (NASDAQ: APDN) was reported by HC Wainwright & Co. on Monday, May 16, 2022. The analyst firm set a price target for 4.00 expecting APDN to rise to within 12 months (a possible 414.93% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Applied DNA Sciences (NASDAQ: APDN) is $0.7768 last updated June 28, 2022, 8:00 PM UTC.
There are no upcoming dividends for Applied DNA Sciences.
Applied DNA Sciences’s Q3 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Applied DNA Sciences.
Applied DNA Sciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.